| 发明名称 |
USE OF PIDOTIMOD TO TREAT INFLAMMATORY BOWEL DISEASE |
| 摘要 |
The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat inflammatory bowel disease. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally. |
| 申请公布号 |
US2016058739(A1) |
申请公布日期 |
2016.03.03 |
| 申请号 |
US201314781796 |
申请日期 |
2013.04.05 |
| 申请人 |
POLICHEM SA |
发明人 |
Mailland Federico;Scarci Francesco;Caserini Maurizio |
| 分类号 |
A61K31/426;A61K9/00;A61K9/08;A61K45/06 |
主分类号 |
A61K31/426 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. Pidotimod or a physiologically acceptable salt thereof, for use in the treatment of inflammatory bowel disease. |
| 地址 |
Luxembourg LU |
